During investigation of vaccine potential of various deletion mutant of GRP170 (37), we found that only chaperoning competent mutants exhibited APC binding activities and could deliver tumor antigen (e.g., gp100) for inducing an antigen-specific anti-tumor immunity (132). This evidence concerns the gene HYOU1 and neoplasm.